__timestamp | Amneal Pharmaceuticals, Inc. | Wave Life Sciences Ltd. |
---|---|---|
Wednesday, January 1, 2014 | 84615000 | 2999000 |
Thursday, January 1, 2015 | 109679000 | 10393000 |
Friday, January 1, 2016 | 118757000 | 15994000 |
Sunday, January 1, 2017 | 109046000 | 26975000 |
Monday, January 1, 2018 | 230435000 | 39509000 |
Tuesday, January 1, 2019 | 289598000 | 48869000 |
Wednesday, January 1, 2020 | 326727000 | 42510000 |
Friday, January 1, 2021 | 365504000 | 46105000 |
Saturday, January 1, 2022 | 399700000 | 50513000 |
Sunday, January 1, 2023 | 429675000 | 51292000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical landscape, understanding the financial strategies of key players is crucial. Over the past decade, Amneal Pharmaceuticals, Inc. and Wave Life Sciences Ltd. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Amneal's SG&A expenses surged by over 400%, reflecting a strategic expansion and increased operational activities. In contrast, Wave Life Sciences exhibited a more modest growth of approximately 1,600%, indicating a steady yet cautious approach to scaling operations.
Amneal's expenses peaked in 2023, reaching nearly five times their 2014 levels, while Wave Life Sciences maintained a consistent upward trajectory, albeit at a slower pace. These trends highlight the contrasting business models and growth strategies of these two companies, offering valuable insights for investors and industry analysts alike.
SG&A Efficiency Analysis: Comparing Novartis AG and Amneal Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Bristol-Myers Squibb Company and Wave Life Sciences Ltd.
Selling, General, and Administrative Costs: Zoetis Inc. vs Amneal Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Alnylam Pharmaceuticals, Inc. vs Amneal Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Genmab A/S and Amneal Pharmaceuticals, Inc.
Comparing SG&A Expenses: Summit Therapeutics Inc. vs Wave Life Sciences Ltd. Trends and Insights
Who Optimizes SG&A Costs Better? Insmed Incorporated or Wave Life Sciences Ltd.
Blueprint Medicines Corporation or Amneal Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Wave Life Sciences Ltd. Trends and Insights
Amneal Pharmaceuticals, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Vericel Corporation
Comparing SG&A Expenses: Vericel Corporation vs Wave Life Sciences Ltd. Trends and Insights